DAB: a three-drug combination provides alternative to 5-HT3 receptor drugs

Oncol Nurs Forum. 1995 May;22(4):718.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Dexamethasone / administration & dosage*
  • Diphenhydramine / administration & dosage*
  • Drug Combinations
  • Humans
  • Lorazepam / administration & dosage*
  • Nausea / chemically induced
  • Nausea / drug therapy*
  • Serotonin Antagonists / therapeutic use*
  • Vomiting / chemically induced
  • Vomiting / drug therapy*

Substances

  • Antineoplastic Agents
  • Drug Combinations
  • Serotonin Antagonists
  • Dexamethasone
  • Diphenhydramine
  • Lorazepam